SHL Telemedicine Reports Second Quarter 2014 Financial Results

  • Revenue increased 39.2% to USD 10.3 million (USD 7.4 million in Q2 2013)
  • Improvement in gross margins to 56.3% from 52.7%
  • EBITDA of USD 1.7 million (16.5% of revenues) with EBIT of USD 0.2 million
  • Net profit of USD 0.1 million
  • Investing in expansion into new territories
  • Confirmed 2014 revenue guidance of over 30% growth year-over-year
Tel Aviv/Zurich, 20 August 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions, today announced results for the second quarter and six months ended 30 June 2014.
For more information click here
Facebook
Twitter
LinkedIn
Pinterest